p53 and HER-2/neu Overexpression in Ovarian Borderline Tumors

By Eltabbakh G.H.   Belinson J.L.   Kennedy A.W.   Biscotti C.V.   Casey G.   Tubbs R.R.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 218-224

Elsevier

Access to resources Recommend Favorite

Lack of prognostic relevance of Her-2/neu, topoisomerase IIα and EGFR in advanced ovarian carcinoma

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 828-834

Spandidos Publications

Access to resources Recommend Favorite

Detection of Her2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry

By          

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1501-1507

Spandidos Publications

Access to resources Recommend Favorite

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

By Latif Z.   Watters A.D.   Dunn I.   Grigor K.   Underwood M.A.   Bartlett J.M.S.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

An Alternative HER-2/neu Transcript of 8 kb Has an Extended 3'UTR and Displays Increased Stability in SKOV-3 Ovarian Carcinoma Cells

By Doherty J.K.   Bond C.T.   Hua W.   Adelman J.P.   Clinton G.M.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 408-415

Elsevier

Access to resources Recommend Favorite